Germany's Fresenius plans to buy America's group APP Pharmaceuticals for $3.7 billion. Ulf Schneider, CEO of Fresenius, spoke to CNBC about the proposed $3.7 billion deal.
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT